Browsing by Author "McGowan, Catherine"

Now showing items 1-6 of 6

    • Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in ... 
      César, Carina; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Mejía, Fernando; Ribeiro, Sayonara Rocha; Cortés Moncada, Claudia; Pape, Jean W.; Sierra Madero, Juan; Fink, Valeria; Sued, Omar; McGowan, Catherine; Cahn, Pedro (Elsevier, 2015)
      Background Access to combination antiretroviral therapy (ART) is expanding in Latin America (Mexico, Central America, and South America) and the Caribbean. We assessed the incidence of and factors associated with regimen ...
    • Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in ... 
      Array, Array; Cesar, Carina; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Mejía, Fernando; Ribeiro, Sayonara Rocha; Cortés Moncada, Claudia; Pape, Jean W.; Madero, Juan Sierra; Fink, Valeria; Sued, Omar; McGowan, Catherine; Cahn, Pedro; Grinsztejn, Beatriz; Reyes, (Elsevier Ltd, 2015)
      © 2015 Elsevier Ltd. Background: Access to combination antiretroviral therapy (ART) is expanding in Latin America (Mexico, Central America, and South America) and the Caribbean. We assessed the incidence of and factors ...
    • Monitoring of HIV treatment in seven countries in the WHO Region of the Americas 
      Belaunzarán Zamudio, Pablo; Caro Vega, Yanink; Shepherd, Bryan; Crabtree Ramírez, Brenda; Luz, Paula; Grinsztejn, Beatriz; Cesar, Carina; Cahn, Pedro; Cortés, Claudia; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo, Eduardo; McGowan, Catherine; Sierra Madero, Juan (World Health Organization, 2015)
      Objective To determine the prevalence of adequate monitoring and the costs of measuring CD4+T-Iymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral load in people receiving antiretroviral therapy (ART) in ...
    • Monitoring of HIV treatment in seven countries in the WHO region of the Americas Suivi du traitement du VIH ... 
      Belaunzarán Zamudio, Pablo; Caro Vega, Yanink; Shepherd, Bryan E.; Crabtree Ramírez, Brenda; Luz, Paula M.; Grinsztejn, Beatriz; Cesar, Carina; Cahn, Pedro; Cortés, Claudia; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo, Eduardo; McGowan, Catherine (World Health Organization, 2015)
      © 2015, World Health Organization. All Rights Reserved. Objective To determine the prevalence of adequate monitoring and the costs of measuring CD4+ T-lymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral ...
    • Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS ... 
      Crabtree Ramírez, Brenda; Caro Vega, Yanink; Shepherd, Bryan E.; Grinsztejn, V; Grinsztejn, Beatriz; Wolff Reyes, Marcelo; Cortés Moncada, Claudia; Padgett, Denis; Carriquiry, Gabriela; Fink, Valeria; Jayathilake, Karu; Person, Anna K.; McGowan, Catherine; Sierra Madero, Juan (Public Library Science, 2016)
      Background Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in ...
    • Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving ... 
      Crabtree Ramírez, Brenda; Jenkins, Cathy A.; Shepherd, Bryan E.; Jayathilake, Karu; Veloso, Valdilea G.; Carriquiry, Gabriela; Gotuzzo, Eduardo; Cortés Moncada, Claudia; Padgett, Dennis; McGowan, Catherine; Sierra Madero, Juan; Koenig, Serena; Pape, Jean W.; Sterling, Timothy R. (BMC, 2022)
      Background Some tuberculosis (TB) treatment guidelines recommend daily TB treatment in both the intensive and continuation phases of treatment in HIV-positive persons to decrease the risk of relapse and acquired drug ...